NEOS insider transactions
Neos Therapeutics, Inc. (NEOS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
NEOS insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Neos Therapeutics, Inc., latest first. Follow anyone to get their next filing.
- John M LimongelliOfficer
- James A. Robinson Jr.Director
- Gerald W. McLaughlinOfficer, Director
- Beth HechtDirector
- John P. SchmidDirector
- Bryant FongDirector
- Linda M SzyperDirector
- Gregory J RobitailleDirector
- Alan L HellerDirector
- Richard I EisenstadtOfficer
Recent Form 3, 4, and 5 filings for NEOS
- SEC Form 4: M John Limongelli disposed to the issuer $0 worth of Common Stock (83,015 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: Jr. A. James Robinson disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: W. Gerald Mclaughlin disposed to the issuer $0 worth of Common Stock (270,171 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: Beth Hecht disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: P. John Schmid disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: Bryant Fong disposed to the issuer $0 worth of Common Stock (24,953 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: M Linda Szyper disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: J Gregory Robitaille disposed to the issuer $0 worth of Common Stock (79,130 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: L Alan Heller disposed to the issuer $0 worth of Common Stock (446,819 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: I Richard Eisenstadt disposed to the issuer $0 worth of Common Stock (126,245 units at $0.00), decreasing direct ownership by 100% to 0 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: W. Gerald Mclaughlin disposed of $37,414 worth of Common Stock (44,329 units at $0.84), decreasing direct ownership by 14% to 270,171 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: M John Limongelli disposed of $14,335 worth of Common Stock (16,985 units at $0.84), decreasing direct ownership by 17% to 83,015 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)
- SEC Form 4: I Richard Eisenstadt disposed of $13,740 worth of Common Stock (16,215 units at $0.85), decreasing direct ownership by 11% to 126,245 units4 - Neos Therapeutics, Inc. (0001467652) (Issuer)